计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| X413957-5mg |
5mg |
现货 ![]() |
| |
| X413957-10mg |
10mg |
现货 ![]() |
| |
| X413957-25mg |
25mg |
现货 ![]() |
| |
| X413957-50mg |
50mg |
现货 ![]() |
| |
| X413957-100mg |
100mg |
期货 ![]() |
|
| 英文别名 | 6H-Pyrimido[4,5-b][1,4]benzodiazepin-6-one,5,11-dihydro-2-[[4-(4-hydroxy-1-piperidinyl)phenyl]amino]-11-methyl- |
|---|---|
| 规格或纯度 | ≥99% |
| 英文名称 | XMD16-5 |
| 生化机理 | XMD16-5 是一种新型酪氨酸激酶非受体 2(TNK2)抑制剂,对 D163E 和 R806Q 突变的 IC50 值分别为 16 nmol/L 和 77 nmol/L。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 产品介绍 |
Information XMD16-5 XMD16-5 is a novel tyrosine kinase nonreceptor 2(TNK2) inhibitor with IC50s of 16 nmol/L and 77 nmol/L for the D163E and R806Q mutations. Targets TNK2 In vitro XMD16-5 is found to be potent in the inhibition of TNK2 phosphorylation. XMD8-87 and XMD16-5 potently inhibit phosphorylation of TNK2 truncation mutations found in solid tumor types. Cell Research(from reference) Cell lines:293T cells Concentrations:10 nM-5 μM Incubation Time:6 h |
| 纯度 | ≥99% |
| ALogP | 2.967 |
|---|---|
| HBD Count | 3 |
| Rotatable Bond | 3 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 488201820 |
|---|---|
| 分子类型 | 未知 |
| IIUPAC Name | 2-[4-(4-hydroxypiperidin-1-yl)anilino]-11-methyl-5H-pyrimido[4,5-b][1,4]benzodiazepin-6-one |
| INCHI | 1S/C23H24N6O2/c1-28-20-5-3-2-4-18(20)22(31)26-19-14-24-23(27-21(19)28)25-15-6-8-16(9-7-15)29-12-10-17(30)11-13-29/h2-9,14,17,30H,10-13H2,1H3,(H,26,31)(H,24,25,27) |
| InChi Key | AGLKBEPKKDHHKY-UHFFFAOYSA-N |
| Smiles | CN1C2=CC=CC=C2C(=O)NC3=CN=C(N=C31)NC4=CC=C(C=C4)N5CCC(CC5)O |
| Isomeric SMILES | CN1C2=CC=CC=C2C(=O)NC3=CN=C(N=C31)NC4=CC=C(C=C4)N5CCC(CC5)O |
| PubChem CID | 57340666 |
| 分子量 | 416.48 |
| 溶解性 | Solubility (25°C) In vitro DMSO: 83 mg/mL (199.28 mM); Ethanol: 5 mg/mL (12.0 mM); Water: Insoluble; |
|---|---|
| DMSO(mg / mL) Max Solubility | 83 |
| DMSO(mM) Max Solubility | 199.2892816 |
| Water(mg / mL) Max Solubility | <1 |
| 分子量 | 416.500 g/mol |
| XLogP3 | 3.000 |
| 氢键供体数Hydrogen Bond Donor Count | 3 |
| 氢键受体数Hydrogen Bond Acceptor Count | 7 |
| 可旋转键计数Rotatable Bond Count | 3 |
| 精确质量Exact Mass | 416.196 Da |
| 单同位素质量Monoisotopic Mass | 416.196 Da |
| 拓扑极表面积Topological Polar Surface Area | 93.600 Ų |
| 重原子数Heavy Atom Count | 31 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 619.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | X413957 | |
| 分析证书 | X413957 | |
| 分析证书 | X413957 | |
| 分析证书 | X413957 | |
| 分析证书 | X413957 | |
| 分析证书 | X413957 | |
| 分析证书 | X413957 | |
| 分析证书 | X413957 | |
| 分析证书 | X413957 | |
| 分析证书 | X413957 |